Heidi Gillenwater

Heidi Gillenwater is a seasoned professional in the field of clinical development, currently holding the position of VP Clinical Development for Cell and Gene Therapy at BioNTech SE. Previously, Heidi served as Vice President of Clinical Development at Lyell Immunopharma and as Senior Medical Director at Juno Therapeutics, Inc. Additionally, Heidi held multiple senior medical director roles at Onyx Pharmaceuticals, Inc., a subsidiary of Amgen, encompassing clinical development and medical affairs. Heidi's academic experience includes the role of Assistant Professor of Medicine in Hematology/Oncology at the University of Virginia Health System.